PCYN Procyon Corp. featured news, full reports, and detailed charts
Procyon Corp. (PCYN/PCYN.OB) Wrap Up:
Procyon Corporation, through its subsidiary, Amerx Health Care Corp., engages in the development and marketing of medical products used in the treatment of pressure ulcers, dermatitis, inflammation, and other skin problems in the United States. Its products include AmeriGel Hydrogel Wound Dressing and Amerigel Hydrogel Saturated Gauze Dressing, which are used as a wound dressing to manage stages I-IV pressure ulcers, stasis ulcers, diabetic skin ulcers, post surgical incisions, cuts, abrasions, first and second degree burns, and skin irritations; and AmeriGel Preventive Care Lotion, a therapeutic skin conditioner containing emollients that restore moisture to fragile skin, protect the skin a...11 Employees
Founded in 1987
Procyon Corp. (PCYN:OTC Bulletin Board Market)
LAST $0.12 USD
CHANGE TODAY 0.00 0.00%
VOLUME 0.0
As of November 16, 2009 All times are local (Market data by Reuters is delayed by at least 15 minutes).
Snapshot of Procyon Corp. (PCYN)
|
OPEN
--
|
PREVIOUS CLOSE
$0.12
|
|
|
DAY HIGH
--
|
DAY LOW
--
|
|
|
52 WEEK HIGH
12/4/08 - $0.25
|
52 WEEK LOW
05/14/09 - $0.06
|
|
|
MARKET CAP
966.6K
|
AVERAGE VOLUME 3 mo
560.0
|
|
|
DILUTED EPS TTM
--
|
SHARES OUTSTANDING
8.1M
|
|
|
PCYN Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
PCYN Top Compensated Officers
Ms. Regina W. Anderson
Chairman, Chief Executive Officer and Preside...
Age: 62
Total Annual Compensation: $154.2K
Mr. James B. Anderson
Chief Financial Officer, Vice President of Op...
Age: 39
Total Annual Compensation: $101.2K
Mr. Justice W. Anderson
Vice President of Sales & Marketing, Director...
Age: 32
Total Annual Compensation: $42.9K
Executives, Board Directors
Compensation as of Fiscal Year 2009.
Key developments for Procyon Corp. (PCYN)
Procyon Corp., Annual General Meeting, Dec 08, 2009
11/9/2009
Procyon Corp., Annual General Meeting, Dec 08, 2009, at 16:00 US Eastern Time. Location: 1300 S. Highland Ave, Clearwater, FL 33756, United States. Agenda: To elect eight directors to hold office for the term set forth in the accompanying Proxy Statement and until their successors shall have been duly elected and qualified; to ratify the appointment of Ferlita, Walsh, & Gonzalez P.A. as independent registered public accountants for the 2010 fiscal year; to approve the company's 2009 stock option plan; and to consider and transact such other business as may properly come before the meeting or any adjournment thereof.
Procyon Corp. Announces Resignation of Alan C. Crane to the Board of Directors and Member of the Ethics Committee of the Board
08/3/2009
Procyon Corp. announced that on July 14, 2009, Alan C. Crane, a director of the company since 1995, tendered his resignation for personal reasons to the board of directors, which regretfully accepted his resignation. Mr. Crane's resignation was not due to any disagreement with the company or its board of directors on any matter relating to the company's operations, policies or practices. At the time of his resignation from the board, Mr. Crane was also a member of the Ethics Committee of the board of directors, and therefore, effectively resigned from that committee as well.
Procyon Corp. Reports Earnings Results for the Third Quarter Ended March 31, 2009
05/18/2009
Procyon Corp. reported earnings results for the third quarter ended March 31, 2009. For the period, the company showing a net income of $28,856. In contrast, the company posted a net income of $12,126 for the same quarter in the previous year.
PCYN Competitors
| Company | Last | Change | |
| No competitor information is available for PCYN. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | PCYN | Industry Range |
| Price/Earnings | 13.3x |
|
| Price/Sales | -- | Not Meaningful |
| Price/Book | 0.5x |
|
| Price/Cash Flow | 39.2x |
|
| TEV/Sales | NM | Not Meaningful |
|
PCYN |
||
|
PCYN transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent News About Procyon Corp.
More news for PCYN
PROCYON CORP Financials
Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-...Click here to read the whole Article (external link)
Skin, wound care products drive gains at Procyon
ONLINE: home | business news | small business | sales & marketing | real estate | events | community | careers | city guide | advertise | about us | rss PRINT: subscribe | renew | advertise | book of lists | business intelligence | classifieds | v...Click here to read the whole Article (external link)
PROCYON CORP Files SEC form 10-Q, Quarterly Report
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. General The following discussion and analysis should be read in conjunction with the unaudited Condensed Financial Statements and Notes thereto appearing elsewhere in this report. This Report on Form 10-Q, including Management's Discussion and Analysis of Financial Condition and Results of Operation, contains forward-looking statements. When used in this report, the words "may," "will," "expect," "anticipate," "continue," "estimate," "project," "intend," "hope," "believe" and similar expressions, variations of these words or the negative of those words, and, any statement regarding possible or assumed future results of operations of the Company's business, the markets for its products, anticipated expenditures, regulatory developments or competition, or other statements regarding matters that are not historical facts, are intended to identify forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 regarding events, conditions and financial trends including, without limitation, business conditions in the skin and wound care market, diabetic market and the general economy, competitive factors, changes in product mix, production delays, manufacturing capabilities, and other risks or uncertainties detailed in other of the Company's Securities and Exchange Commission filings. Such statements are based on management's current expectations and are subject to risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual plan of operations, business strategy, operating results and financial position could differ materially from those expressed in, or implied by, such forward-...Click here to read the whole Article (external link)
Fee increases cut Procyon profit
ONLINE: home | business news | small business | sales & marketing | real estate | events | community | careers | city guide | advertise | about us | rss PRINT: subscribe | renew | advertise | book of lists | business intelligence | classifieds | v...Click here to read the whole Article (external link)
PROCYON CORP Files SEC form 10-K, Annual Report
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 This Report on Form 10-K, including Management's Discussion and Analysis or Plan of Operation, contains forward-looking statements. When used in this report, the words "may", "will", "expect", "anticipate", "continue", "estimate", "project", "intend", "hope", "believe" and similar expressions, variations of these words or the negative of those words, and, any statement regarding possible or assumed future results of operations of the Company's and its subsidiaries' business, the markets for its products, anticipated expenditures, regulatory developments or competition, or other statements regarding matters that are not historical facts, are intended to identify forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 regarding events, conditions and financial trends including, without limitation, business conditions in the skin and wound care market and the general economy, competitive factors, changes in product mix, production delays, manufacturing capabilities, new and unanticipated governmental regulations and other risks or uncertainties detailed in other of the Company's Securities and Exchange Commission filings. Such statements are based on management's current expectations and are subject to risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual plan of operations, business strategy, operating results and financial position could differ materially from those expressed in, or implied by, such forward-looking statements. Our business in general is subject to certain risks includin...Click here to read the whole Article (external link)
PROCYON CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition
Show all filings for PROCYON CORP | Request a Trial to NEW EDGAR Online Pro Form 8-K for PROCYON CORP 3-Aug-2009Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information prov...Click here to read the whole Article (external link)
PROCYON CORP Files SEC form 10-Q, Quarterly Report
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. General The following discussion and analysis should be read in conjunction with the unaudited Condensed Financial Statements and Notes thereto appearing elsewhere in this report. This Report on Form 10-Q, including Management's Discussion and Analysis of Financial Condition and Results of Operation, contains forward-looking statements. When used in this report, the words "may," "will," "expect," "anticipate," "continue," "estimate," "project," "intend," "hope," "believe" and similar expressions, variations of these words or the negative of those words, and, any statement regarding possible or assumed future results of operations of the Company's business, the markets for its products, anticipated expenditures, regulatory developments or competition, or other statements regarding matters that are not historical facts, are intended to identify forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 regarding events, conditions and financial trends including, without limitation, business conditions in the skin and wound care market, diabetic market and the general economy, competitive factors, changes in product mix, production delays, manufacturing capabilities, and other risks or uncertainties detailed in other of the Company's Securities and Exchange Commission filings. Such statements are based on management's current expectations and are subject to risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual plan of operations, business strategy, operating results and financial position could differ materially from those expressed in, or implied by, such forward...Click here to read the whole Article (external link)
PROCYON CORP Files SEC form 10-Q, Quarterly Report
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. General The following discussion and analysis should be read in conjunction with the unaudited Condensed Financial Statements and Notes thereto appearing elsewhere in this report. "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995 This Report on Form 10-Q, including Management's Discussion and Analysis of Financial Condition and Results of Operation, contains forward-looking statements. When used in this report, the words "may," "will," "expect," "anticipate," "continue," "estimate," "project," "intend," "hope," "believe" and similar expressions, variations of these words or the negative of those words, and, any statement regarding possible or assumed future results of operations of the Company's business, the markets for its products, anticipated expenditures, regulatory developments or competition, or other statements regarding matters that are not historical facts, are intended to identify forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 regarding events, conditions and financial trends including, without limitation, business conditions in the skin and wound care market, diabetic market and the general economy, competitive factors, changes in product mix, production delays, manufacturing capabilities, and other risks or uncertainties detailed in other of the Company's Securities and Exchange Commission filings. Such statements are based on management's current expectations and are subject to risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual plan of operations, business strategy, operating results and fin...Click here to read the whole Article (external link)
PROCYON CORP Files SEC form 10-Q, Quarterly Report
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. GENERAL The following discussion and analysis should be read in conjunction with the unaudited Condensed Financial Statements and Notes thereto appearing elsewhere in this report. "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995 This Report on Form 10-Q, including Management's Discussion and Analysis of Financial Condition and Results of Operations, contains forward-looking statements. When used in this report, the words "may," "will," "expect," "anticipate," "continue," "estimate," "project," "intend," "hope," "believe" and similar expressions, variations of these words or the negative of those words, and, any statement regarding possible or assumed future results of operations of the Company's business, the markets for its products, anticipated expenditures, regulatory developments or competition, or other statements regarding matters that are not historical facts, are intended to identify forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 regarding events, conditions and financial trends including, without limitation, business conditions in the skin and wound care market, diabetic market and the general economy, competitive factors, changes in product mix, production delays, manufacturing capabilities, and other risks or uncertainties detailed in other of the Company's Securities and Exchange Commission filings. Such statements are based on management's current expectations and are subject to risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual plan of operations, business strategy, operating results and fin...Click here to read the whole Article (external link)
Would you like to leave a comment about Procyon Corp. PCYN/PCYN.OB
Find out what social network information about Procyon Corp. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides Procyon Corp. there is more great information available at Realpennies.com